Extracellular Matrix Sterilization via Supercritical CO2

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for sterilizing and decellularizing extracellular matrix compositions for treating cardiac arrhythmias often alter the tissue properties, fail to completely sterilize, or leave residual contaminants, necessitating separate processes that are time-consuming and inefficient.

Innovation Solution

A method involving the harvesting and processing of extracellular matrix tissue through freezing, thawing, incubation, rinsing, and exposure to supercritical carbon dioxide with rapid depressurization, allowing for simultaneous sterilization and decellularization while enhancing the incorporation of additives, such as growth factors, to create a sterilized, acellular composition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional sterilization techniques (ethylene oxide, steam, gamma radiation) are used on extracellular matrix compositions, then sterilization is achieved, but the tissue properties are altered and important components such as growth factors are damaged or destroyed

Engineering Contradiction:
Improvesterilization effectivenessVSAvoidtissue composition integrity
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent changes the physical state parameters of carbon dioxide to supercritical conditions (temperature above 31.1°C and pressure above 73.8 atm), which allows the fluid to penetrate tissue pores effectively for sterilization while avoiding the damaging chemical effects of conventional sterilization methods. The composition remains stable because supercritical CO2 is non-reactive with tissue components.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes the phase transition of carbon dioxide between supercritical and gaseous states. During sterilization, CO2 is maintained in supercritical state for penetration and sterilization effect. During rapid depressurization, it transitions to gaseous state, creating the popping sound and enhancing additive incorporation. This phase transition enables effective sterilization without leaving residual contaminants that could damage tissue composition.

Inventive Principle:
Principle #36Phase transitions

2Reliability

If separate sterilization and decellularization processes are used, then both functions are achieved, but the process becomes time-consuming and inefficient

Engineering Contradiction:
Improvesterilization and decellularization effectivenessVSAvoidprocessing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent merges sterilization and decellularization into a single integrated process using supercritical carbon dioxide. The supercritical fluid simultaneously kills microorganisms and removes cellular material from the extracellular matrix, achieving both sterilization and decellularization objectives in one step rather than requiring separate sequential processes.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

Supercritical carbon dioxide serves multiple functions simultaneously: it acts as a sterilizing agent, a decellularizing agent, and a vehicle for delivering growth factors and other additives to the tissue. This multi-functionality eliminates the need for multiple separate processing steps.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If conventional decellularization techniques are used, then partial decellularization is achieved, but native cells remain in the tissue compositions

Engineering Contradiction:
Improvedecellularization effectivenessVSAvoidacellular composition purity
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent uses extreme parameter changes - rapid depressurization from supercritical to atmospheric conditions - to enhance the decellularization process. This sudden pressure change creates physical forces that more effectively remove native cells from the tissue matrix, achieving more complete decellularization than conventional gradual methods.

Inventive Principle:
Principle #35Parameter changes

4Quantity of substance

If rapid depressurization is applied during or after sterilization, then additive incorporation is enhanced, but the process complexity increases

Engineering Contradiction:
Improveadditive incorporationVSAvoidprocessing process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by incorporating growth factors and other additives into the supercritical carbon dioxide before it contacts the tissue. This pre-loading of the supercritical fluid ensures that additives are delivered directly to the tissue during the sterilization/decellularization process, maximizing incorporation efficiency.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method maintains the native properties of the extracellular matrix, achieves effective sterilization and decellularization, and enhances the incorporation of additives, providing a more efficient and effective treatment for cardiac arrhythmias.

Implementation Method 1

exposure to supercritical carbon dioxide with rapid depressurization, allowing for simultaneous sterilization and decellularization

Methodology Applied
Scientific EffectSupercritical fluid extraction: Supercritical Fluid Extraction

Implementation Method 2

exposure to supercritical carbon dioxide with rapid depressurization, allowing for simultaneous sterilization and decellularization while enhancing the incorporation of additives

Methodology Applied
Scientific EffectRapid depressurization: Depressurisation

Implementation Method 3

The methods include harvesting of a selected ECM tissue, freezing the selected ECM tissue, thawing the selected ECM tissue

Methodology Applied
Scientific EffectFreezing: Freezing

Implementation Method 4

freezing the selected ECM tissue, thawing the selected ECM tissue

Methodology Applied
Scientific EffectThawing: Melting

Data Source

PatentUS9060969B2Compositions for preventing cardiac arrhythmia
Publication Date: 2015.06.23 CORVIVO CARDIOVASCULAR INC
  • US9060969B2 patent drawing
  • US9060969B2 patent drawing
  • US9060969B2 patent drawing

AI summary

Disclosed herein are compositions and methods for treating or preventing a cardiac arrhythmia in a subject.